CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer Activity

被引:71
作者
Assimon, Victoria A. [1 ]
Tang, Yangzhong [1 ]
Vargas, Jesse D. [1 ]
Lee, Grace J. [1 ]
Wu, Zhi Yong [1 ]
Lou, Kenny [1 ]
Yao, Bing [1 ]
Menon, Mary-Kamala [1 ]
Pios, Ariel [1 ]
Perez, Kristy C. [1 ]
Madriaga, Antonett [1 ]
Buchowiecki, Peter K. [1 ]
Rolfe, Mark [1 ]
Shawver, Laura [1 ]
Jiao, Xianyun [1 ]
Le Moigne, Ronan [1 ]
Zhou, Han-Jie [1 ]
Anderson, Daniel J. [1 ]
机构
[1] Cleave Biosci Inc, Burlingame, CA 94010 USA
关键词
CHROMATIN REMODELING COMPLEX; INCREASED PONTIN EXPRESSION; HEPATOCELLULAR-CARCINOMA; ATPASE ACTIVITY; TERMINAL TAIL; REPTIN; INO80; CANCER; PONTIN/REPTIN; GROWTH;
D O I
10.1021/acschembio.8b00904
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RUVBL1 and RUVBL2 are ATPases associated with diverse cellular activities (AAAs) that form a complex involved in a variety of cellular processes, including chromatin remodeling and regulation of gene expression. RUVBLs have a strong link to oncogenesis, where overexpression is correlated with tumor growth and poor prognosis in several cancer types. CB-6644, an allosteric small-molecule inhibitor of the ATPase activity of the RUVBL1/2 complex, interacts specifically with RUVBL1/2 in cancer cells, leading to cell death. Importantly, drug-acquired-resistant cell clones have amino acid mutations in either RUVBL1 or RUVBL2, suggesting that cell killing is an on-target consequence of RUVBL1/2 engagement. In xenograft models of acute myeloid leukemia and multiple myeloma, CB-6644 significantly reduced tumor growth without obvious toxicity. This work demonstrates the therapeutic potential of targeting RUVBLs in the treatment of cancer and establishes a chemical entity for probing the many facets of RUVBL biology.
引用
收藏
页码:236 / 244
页数:9
相关论文
共 38 条
[1]   Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting [J].
Aguirre, Andrew J. ;
Meyers, Robin M. ;
Weir, Barbara A. ;
Vazquez, Francisca ;
Zhang, Cheng-Zhong ;
Ben-David, Uri ;
Cook, April ;
Ha, Gavin ;
Harrington, William F. ;
Doshi, Mihir B. ;
Kost-Alimova, Maria ;
Gill, Stanley ;
Xu, Han ;
Ali, Levi D. ;
Jiang, Guozhi ;
Pantel, Sasha ;
Lee, Yenarae ;
Goodale, Amy ;
Cherniack, Andrew D. ;
Oh, Coyin ;
Kryukov, Gregory ;
Cowley, Glenn S. ;
Garraway, Levi A. ;
Stegmaier, Kimberly ;
Roberts, Charles W. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Root, David E. ;
Tsherniak, Aviad ;
Hahn, William C. .
CANCER DISCOVERY, 2016, 6 (08) :914-929
[2]   Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis [J].
Anderson, Daniel J. ;
Le Moigne, Ronan ;
Djakovic, Stevan ;
Kumar, Brajesh ;
Rice, Julie ;
Wong, Steve ;
Wang, Jinhai ;
Yao, Bing ;
Valle, Eduardo ;
von Soly, Szerenke Kiss ;
Madriaga, Antonett ;
Soriano, Ferdie ;
Menon, Mary-Kamala ;
Wu, Zhi Yong ;
Kampmann, Martin ;
Chen, Yuwen ;
Weissman, Jonathan S. ;
Aftab, Blake T. ;
Yakes, F. Michael ;
Shawver, Laura ;
Zhou, Han-Jie ;
Wustrow, David ;
Rolfe, Mark .
CANCER CELL, 2015, 28 (05) :653-665
[3]   SnapShot: Chromatin Remodeling: INO80 and SWR1 [J].
Bao, Yunhe ;
Shen, Xuetong .
CELL, 2011, 144 (01) :158-U165
[4]   Nucleosome Remodeling and Epigenetics [J].
Becker, Peter B. ;
Workman, Jerry L. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2013, 5 (09)
[5]   Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development [J].
Bellosta, P ;
Hulf, T ;
Diop, SB ;
Usseglio, F ;
Pradel, J ;
Aragnol, D ;
Gallant, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (33) :11799-11804
[6]   Pontin is a critical regulator for AML1-ETO-induced leukemia [J].
Breig, O. ;
Bras, S. ;
Soria, N. Martinez ;
Osman, D. ;
Heidenreich, O. ;
Haenlin, M. ;
Waltzer, L. .
LEUKEMIA, 2014, 28 (06) :1271-1279
[7]  
Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P77, DOI [10.1139/O09-159, 10.1139/o09-159]
[8]   TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis [J].
Dugan, KA ;
Wood, MA ;
Cole, MD .
ONCOGENE, 2002, 21 (38) :5835-5843
[9]  
Ebisawa M, 2014, Patent, Patent No. [WO/2015/125786, 2015125786]
[10]   Structural and functional insights into a dodecameric molecular machine - The RuvBL1/RuvBL2 complex [J].
Gorynia, Sabine ;
Bandeiras, Tiago M. ;
Pinho, Filipa G. ;
McVey, Colin E. ;
Vonrhein, Clemens ;
Round, Adam ;
Svergun, Dmitri I. ;
Donner, Peter ;
Matias, Pedro M. ;
Carrondo, Maria Armenia .
JOURNAL OF STRUCTURAL BIOLOGY, 2011, 176 (03) :279-291